Markel Cash & Equivalents decreased by 7.2% to $3.68B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.2%, from $4.19B to $3.68B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows relatively stable performance with a -1.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.68B | $3.94B | $3.98B | $3.89B | $3.70B | $3.54B | $4.14B | $4.03B | $4.31B | $4.35B | $3.75B | $3.63B | $3.51B | $3.87B | $3.69B | $4.19B | $3.72B | $4.05B | $3.96B | $3.68B |
| QoQ Change | — | +7.0% | +1.0% | -2.2% | -4.9% | -4.3% | +16.9% | -2.5% | +6.8% | +1.1% | -14.0% | -3.2% | -3.2% | +10.3% | -4.7% | +13.6% | -11.3% | +8.8% | -2.1% | -7.2% |
| YoY Change | — | — | — | — | +0.5% | -10.1% | +4.0% | +3.6% | +16.4% | +23.0% | -9.4% | -10.0% | -18.5% | -11.1% | -1.5% | +15.6% | +6.0% | +4.5% | +7.4% | -12.2% |